{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:47:47Z","timestamp":1792043267489,"version":"4.4.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"DOI":"10.1038\/s41418-026-01885-5","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:15:11Z","timestamp":1792041311000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["USP25 augments XIAP-mediated signaling to safeguard intestinal homeostasis"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4316-3379","authenticated-orcid":false,"given":"Jiangyun","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshuo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqi","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9014-0055","authenticated-orcid":false,"given":"Wenhua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3646-2918","authenticated-orcid":false,"given":"Jing","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6171-0490","authenticated-orcid":false,"given":"Yangping","family":"Shentu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8428-9339","authenticated-orcid":false,"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"1885_CR1","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0140-6736(23)02586-2","volume":"403","author":"M Dolinger","year":"2024","unstructured":"Dolinger M, Torres J, Vermeire S. Crohn\u2019s disease. Lancet. 2024;403:1177\u201391.","journal-title":"Lancet"},{"key":"1885_CR2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.molmed.2022.01.006","volume":"28","author":"J Ruan","year":"2022","unstructured":"Ruan J, Schl\u00fcter D, Naumann M, Waisman A, Wang X. Ubiquitin-modifying enzymes as regulators of colitis. Trends Mol Med. 2022;28:304\u201318.","journal-title":"Trends Mol Med"},{"key":"1885_CR3","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","volume":"389","author":"J Torres","year":"2016","unstructured":"Torres J, Mehandru S, Colombel J-F, Peyrin-Biroulet L. Crohn\u2019s disease. Lancet. 2016;389:1741\u201355.","journal-title":"Lancet"},{"key":"1885_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/35079107","volume":"411","author":"JP Hugot","year":"2001","unstructured":"Hugot JP, Chamaillard M, Zouali H, Lesage S, C\u00e9zard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease. Nature. 2001;411:599\u2013603.","journal-title":"Nature"},{"key":"1885_CR5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/35079114","volume":"411","author":"Y Ogura","year":"2001","unstructured":"Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn\u2019s disease. Nature. 2001;411:603\u20136.","journal-title":"Nature"},{"key":"1885_CR6","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/med.21711","volume":"40","author":"X Wang","year":"2020","unstructured":"Wang X, Antony V, Wang Y, Wu G, Liang G. Pattern recognition receptor-mediated inflammation in diabetic vascular complications. Med Res Rev. 2020;40:2466\u201384.","journal-title":"Med Res Rev"},{"key":"1885_CR7","doi-asserted-by":"publisher","first-page":"8869","DOI":"10.1074\/jbc.C200651200","volume":"278","author":"SE Girardin","year":"2003","unstructured":"Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem. 2003;278:8869\u201372.","journal-title":"J Biol Chem"},{"key":"1885_CR8","doi-asserted-by":"crossref","unstructured":"Philpott DJ, Sorbara MT, Robertson SJ, Croitoru K, Girardin SE. NOD proteins: regulators of inflammation in health and disease. Nat Rev Immunol. 2013;14:9\u201323.","DOI":"10.1038\/nri3565"},{"key":"1885_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/sj.emboj.7601962","volume":"27","author":"M Hasegawa","year":"2007","unstructured":"Hasegawa M, Fujimoto Y, Lucas PC, Nakano H, Fukase K, N\u00fa\u00f1ez G, et al. A critical role of RICK\/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. EMBO J. 2007;27:373\u201383.","journal-title":"EMBO J"},{"key":"1885_CR10","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ncb3358","volume":"18","author":"R Yau","year":"2016","unstructured":"Yau R, Rape M. The increasing complexity of the ubiquitin code. Nat Cell Biol. 2016;18:579\u201386.","journal-title":"Nat Cell Biol"},{"key":"1885_CR11","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/ni.2669","volume":"14","author":"S Yang","year":"2013","unstructured":"Yang S, Wang B, Humphries F, Jackson R, Healy ME, Bergin R, et al. Pellino3 ubiquitinates RIP2 and mediates Nod2-induced signaling and protective effects in colitis. Nat Immunol. 2013;14:927\u201336.","journal-title":"Nat Immunol"},{"key":"1885_CR12","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.molcel.2012.04.014","volume":"46","author":"RB Damgaard","year":"2012","unstructured":"Damgaard RB, Nachbur U, Yabal M, Wong WW-L, Fiil BK, Kastirr M, et al. The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. Mol Cell. 2012;46:746\u201358.","journal-title":"Mol Cell"},{"key":"1885_CR13","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1038\/s44319-024-00276-6","volume":"25","author":"J Shen","year":"2024","unstructured":"Shen J, Lou L, Du X, Zhou B, Xu Y, Mei F, et al. YOD1 sustains NOD2-mediated protective signaling in colitis by stabilizing RIPK2. EMBO Rep. 2024;25:4827\u201345.","journal-title":"EMBO Rep"},{"key":"1885_CR14","doi-asserted-by":"crossref","unstructured":"Zhou B, Yin M, Su X, Sheng S, Du X, Shen J, et al. DUBA sustains the stability of NOD2 and RIPK2 to enhance innate immune responses. Cell Death Differ. 2025;32:2053\u201365.","DOI":"10.1038\/s41418-025-01516-5"},{"key":"1885_CR15","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/ni.2427","volume":"13","author":"B Zhong","year":"2012","unstructured":"Zhong B, Liu X, Wang X, Chang SH, Liu X, Wang A, et al. Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25. Nat Immunol. 2012;13:1110\u20137.","journal-title":"Nat Immunol"},{"key":"1885_CR16","doi-asserted-by":"publisher","first-page":"ra35","DOI":"10.1126\/scisignal.2003708","volume":"6","author":"B Zhong","year":"2013","unstructured":"Zhong B, Liu X, Wang X, Liu X, Li H, Darnay BG, et al. Ubiquitin-specific protease 25 regulates TLR4-dependent innate immune responses through deubiquitination of the adaptor protein TRAF3. Sci Signal. 2013;6:ra35.","journal-title":"Sci Signal"},{"key":"1885_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110877","volume":"124","author":"B Liu","year":"2023","unstructured":"Liu B, Miao X, Shen J, Lou L, Chen K, Mei F, et al. USP25 ameliorates diabetic nephropathy by inhibiting TRAF6-mediated inflammatory responses. Int Immunopharmacol. 2023;124:110877.","journal-title":"Int Immunopharmacol"},{"key":"1885_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301641","volume":"10","author":"Z Li","year":"2023","unstructured":"Li Z, Liu B, Lambertsen KL, Clausen BH, Zhu Z, Du X, et al. USP25 inhibits neuroinflammatory responses after cerebral ischemic stroke by deubiquitinating TAB2. Adv Sci (Weinh). 2023;10:e2301641.","journal-title":"Adv Sci (Weinh)"},{"key":"1885_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45977-7","volume":"15","author":"P Jiang","year":"2024","unstructured":"Jiang P, Jing Y, Zhao S, Lan C, Yang L, Dai X, et al. Expression of USP25 associates with fibrosis, inflammation and metabolism changes in IgG4-related disease. Nat Commun. 2024;15:2627.","journal-title":"Nat Commun"},{"key":"1885_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature11582","volume":"491","author":"L Jostins","year":"2012","unstructured":"Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119\u201324.","journal-title":"Nature"},{"key":"1885_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MIB.0000000000000268","volume":"21","author":"S-K Yang","year":"2015","unstructured":"Yang S-K, Hong M, Choi H, Zhao W, Jung Y, Haritunians T, et al. Immunochip analysis identification of 6 additional susceptibility loci for Crohn\u2019s disease in Koreans. Inflamm Bowel Dis. 2015;21:1\u20137.","journal-title":"Inflamm Bowel Dis"},{"key":"1885_CR22","doi-asserted-by":"crossref","unstructured":"Brant SR, Okou DT, Simpson CL, Cutler DJ, Haritunians T, Bradfield JP, et al. Genome-wide association study identifies African-specific susceptibility loci in African Americans With Inflammatory Bowel Disease. Gastroenterology. 2016;152:206\u201317.","DOI":"10.1053\/j.gastro.2016.09.032"},{"key":"1885_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07315-z","volume":"16","author":"Z Liu","year":"2025","unstructured":"Liu Z, Liu J, Wei Y, Li J, Zhang J, Yu R, et al. Ubiquitin-specific protease 25 ameliorates ulcerative colitis by regulating the degradation of phosphor-STAT3. Cell Death Dis. 2025;16:5.","journal-title":"Cell Death Dis"},{"key":"1885_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2026.106213","volume":"126","author":"X Su","year":"2026","unstructured":"Su X, Zhou B, Xu Y, Du X, Chen J, Yin M, et al. USP25 regulates atherosclerosis by restricting RIPK1-mediated inflammatory responses. EBioMedicine. 2026;126:106213.","journal-title":"EBioMedicine"},{"key":"1885_CR25","doi-asserted-by":"crossref","unstructured":"Hrdinka M, Schlicher L, Dai B, Pinkas DM, Bufton JC, Picaud S, et al. Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling. EMBO J. 2018;37:e99372.","DOI":"10.15252\/embj.201899372"},{"key":"1885_CR26","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.semcdb.2020.07.001","volume":"109","author":"Y Topal","year":"2020","unstructured":"Topal Y, Gyrd-Hansen M. RIPK2 NODs to XIAP and IBD. Semin Cell Dev Biol. 2020;109:144\u201350.","journal-title":"Semin Cell Dev Biol"},{"key":"1885_CR27","doi-asserted-by":"crossref","unstructured":"Goncharov T, Hedayati S, Mulvihill MM, Izrael-Tomasevic A, Zobel K, Jeet S, et al. Disruption of XIAP-RIP2 association blocks NOD2-mediated inflammatory signaling. Mol Cell. 2018;69:551\u201365.","DOI":"10.1016\/j.molcel.2018.01.016"},{"key":"1885_CR28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.immuni.2008.02.002","volume":"28","author":"O Hitotsumatsu","year":"2008","unstructured":"Hitotsumatsu O, Ahmad R-C, Tavares R, Wang M, Philpott D, Turer EE, et al. The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals. Immunity. 2008;28:381\u201390.","journal-title":"Immunity"},{"key":"1885_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41380-021-01233-8","volume":"27","author":"B Liu","year":"2021","unstructured":"Liu B, Ruan J, Chen M, Li Z, Manjengwa G, Schl\u00fcter D, et al. Deubiquitinating enzymes (DUBs): decipher underlying basis of neurodegenerative diseases. Mol Psychiatry. 2021;27:259\u201368.","journal-title":"Mol Psychiatry"},{"key":"1885_CR30","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1161\/CIRCRESAHA.122.321849","volume":"132","author":"B Ye","year":"2023","unstructured":"Ye B, Zhou H, Chen Y, Luo W, Lin W, Zhao Y, et al. USP25 ameliorates pathological cardiac hypertrophy by stabilizing SERCA2a in cardiomyocytes. Circ Res. 2023;132:465\u201380.","journal-title":"Circ Res"},{"key":"1885_CR31","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/emmm.201303090","volume":"5","author":"RB Damgaard","year":"2013","unstructured":"Damgaard RB, Fiil BK, Speckmann C, Yabal M, zur Stadt U, Bekker-Jensen S, et al. Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling. EMBO Mol Med. 2013;5:1278\u201395.","journal-title":"EMBO Mol Med"},{"key":"1885_CR32","doi-asserted-by":"crossref","unstructured":"Lethier M, Huard K, Hons M, Favier A, Brutscher B, Boeri Erba E, et al. Structure shows that the BIR2 domain of E3 ligase XIAP binds across the RIPK2 kinase dimer interface. Life Sci Alliance. 2023;6:e202201784.","DOI":"10.26508\/lsa.202201784"},{"key":"1885_CR33","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1053\/gast.2002.32415","volume":"122","author":"AP Cuthbert","year":"2002","unstructured":"Cuthbert AP, Fisher SA, Mirza MM, King K, Hampe J, Croucher PJP, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology. 2002;122:867\u201374.","journal-title":"Gastroenterology"},{"key":"1885_CR34","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0016-5085(89)80079-4","volume":"96","author":"GP Morris","year":"1989","unstructured":"Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 1989;96:795\u2013803.","journal-title":"Gastroenterology"},{"key":"1885_CR35","doi-asserted-by":"publisher","first-page":"G41","DOI":"10.1152\/ajpgi.00358.2010","volume":"300","author":"X-Z Shi","year":"2010","unstructured":"Shi X-Z, Winston JH, Sarna SK. Differential immune and genetic responses in rat models of Crohn\u2019s colitis and ulcerative colitis. Am J Physiol Gastrointest Liver Physiol. 2010;300:G41\u2013G51.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1885_CR36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/40901","volume":"388","author":"QL Deveraux","year":"1997","unstructured":"Deveraux QL, Takahashi R, Salvesen GS, Reed JC. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 1997;388:300\u20134.","journal-title":"Nature"},{"key":"1885_CR37","doi-asserted-by":"publisher","first-page":"7003","DOI":"10.1128\/MCB.24.16.7003-7014.2004","volume":"24","author":"JC Wilkinson","year":"2004","unstructured":"Wilkinson JC, Cepero E, Boise LH, Duckett CS. Upstream regulatory role for XIAP in receptor-mediated apoptosis. Mol Cell Biol. 2004;24:7003\u201314.","journal-title":"Mol Cell Biol"},{"key":"1885_CR38","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1093\/ecco-jcc\/jjab013","volume":"15","author":"I Chang","year":"2021","unstructured":"Chang I, Park S, Lee H-J, Kim I, Park S, Ahn MK, et al. Interpretation of XIAP variants of uncertain significance in paediatric patients with refractory Crohn\u2019s disease. J Crohns Colitis. 2021;15:1291\u2013304.","journal-title":"J Crohns Colitis"},{"key":"1885_CR39","doi-asserted-by":"crossref","unstructured":"Aguilar C, Lenoir C, Lambert N, B\u00e8gue B, Brousse N, Canioni D, et al. Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers. J Allergy Clin Immunol. 2014;134:1131\u201341.","DOI":"10.1016\/j.jaci.2014.04.031"},{"key":"1885_CR40","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.celrep.2018.01.024","volume":"22","author":"CA Stafford","year":"2018","unstructured":"Stafford CA, Lawlor KE, Heim VJ, Bankovacki A, Bernardini JP, Silke J, et al. IAPs regulate distinct innate immune pathways to co-ordinate the response to bacterial peptidoglycans. Cell Rep. 2018;22:1496\u2013508.","journal-title":"Cell Rep"},{"key":"1885_CR41","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1126\/science.288.5467.874","volume":"288","author":"Y Yang","year":"2000","unstructured":"Yang Y, Fang S, Jensen JP, Weissman AM, Ashwell JD. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science. 2000;288:874\u20137.","journal-title":"Science"},{"key":"1885_CR42","doi-asserted-by":"publisher","first-page":"25729","DOI":"10.1074\/jbc.M111.241893","volume":"286","author":"YS Ryu","year":"2011","unstructured":"Ryu YS, Lee Y, Lee KW, Hwang CY, Maeng J-S, Kim J-H, et al. TRIM32 protein sensitizes cells to tumor necrosis factor (TNF\u03b1)-induced apoptosis via its RING domain-dependent E3 ligase activity against X-linked inhibitor of apoptosis (XIAP). J Biol Chem. 2011;286:25729\u201338.","journal-title":"J Biol Chem"},{"key":"1885_CR43","doi-asserted-by":"publisher","first-page":"851","DOI":"10.15252\/emmm.201506047","volume":"8","author":"K Engel","year":"2016","unstructured":"Engel K, Rudelius M, Slawska J, Jacobs L, Ahangarian Abhari B, Altmann B, et al. USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma. EMBO Mol Med. 2016;8:851\u201362.","journal-title":"EMBO Mol Med"},{"key":"1885_CR44","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1038\/s41388-022-02486-5","volume":"41","author":"G Saha","year":"2022","unstructured":"Saha G, Sarkar S, Mohanta PS, Kumar K, Chakrabarti S, Basu M, et al. USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma. Oncogene. 2022;41:5061\u201375.","journal-title":"Oncogene"},{"key":"1885_CR45","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ebiom.2016.12.014","volume":"15","author":"Z Zhou","year":"2016","unstructured":"Zhou Z, Luo A, Shrivastava I, He M, Huang Y, Bahar I, et al. Regulation of XIAP turnover reveals a role for USP11 in promotion of tumorigenesis. EBioMedicine. 2016;15:48\u201361.","journal-title":"EBioMedicine"},{"key":"1885_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39412-6","volume":"14","author":"C Cai","year":"2023","unstructured":"Cai C, Ma H, Peng J, Shen X, Zhen X, Yu C, et al. USP25 regulates KEAP1-NRF2 anti-oxidation axis and its inactivation protects acetaminophen-induced liver injury in male mice. Nat Commun. 2023;14:3648.","journal-title":"Nat Commun"},{"key":"1885_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29684-9","volume":"13","author":"JK Nelson","year":"2022","unstructured":"Nelson JK, Thin MZ, Evan T, Howell S, Wu M, Almeida B, et al. USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer. Nat Commun. 2022;13:2070.","journal-title":"Nat Commun"},{"key":"1885_CR48","doi-asserted-by":"crossref","unstructured":"Jost PJ, Vucic D. Regulation of Cell Death and Immunity by XIAP. Cold Spring Harb Perspect Biol. 2020;12:a036426.","DOI":"10.1101\/cshperspect.a036426"},{"key":"1885_CR49","doi-asserted-by":"crossref","unstructured":"Silke J, Meier P. Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation. Cold Spring Harb Perspect Biol. 2013;5:a008730.","DOI":"10.1101\/cshperspect.a008730"},{"key":"1885_CR50","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.celrep.2017.09.052","volume":"21","author":"N Edison","year":"2017","unstructured":"Edison N, Curtz Y, Paland N, Mamriev D, Chorubczyk N, Haviv-Reingewertz T, et al. Degradation of Bcl-2 by XIAP and ARTS promotes apoptosis. Cell Rep. 2017;21:442\u201354.","journal-title":"Cell Rep"},{"key":"1885_CR51","doi-asserted-by":"publisher","first-page":"36611","DOI":"10.1074\/jbc.M200317200","volume":"277","author":"M MacFarlane","year":"2002","unstructured":"MacFarlane M, Merrison W, Bratton SB, Cohen GM. Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro. J Biol Chem. 2002;277:36611\u20136.","journal-title":"J Biol Chem"},{"key":"1885_CR52","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/cdd.2009.81","volume":"17","author":"S Galb\u00e1n","year":"2010","unstructured":"Galb\u00e1n S, Duckett CS. XIAP as a ubiquitin ligase in cellular signaling. Cell Death Differ. 2010;17:54\u201360.","journal-title":"Cell Death Differ"},{"key":"1885_CR53","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf7473","volume":"6","author":"A Strigli","year":"2021","unstructured":"Strigli A, Gopalakrishnan S, Zeissig Y, Basic M, Wang J, Schwerd T, et al. Deficiency in X-linked inhibitor of apoptosis protein promotes susceptibility to microbial triggers of intestinal inflammation. Sci Immunol. 2021;6:eabf7473.","journal-title":"Sci Immunol"},{"key":"1885_CR54","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf7235","volume":"6","author":"A Wahida","year":"2021","unstructured":"Wahida A, M\u00fcller M, Hiergeist A, Popper B, Steiger K, Branca C, et al. XIAP restrains TNF-driven intestinal inflammation and dysbiosis by promoting innate immune responses of Paneth and dendritic cells. Sci Immunol. 2021;6:eabf7235.","journal-title":"Sci Immunol"},{"key":"1885_CR55","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/GIM.0b013e3182088158","volume":"13","author":"EA Worthey","year":"2011","unstructured":"Worthey EA, Mayer AN, Syverson GD, Helbling D, Bonacci BB, Decker B, et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med. 2011;13:255\u201362.","journal-title":"Genet Med"},{"key":"1885_CR56","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1136\/gutjnl-2013-306520","volume":"64","author":"Y Zeissig","year":"2014","unstructured":"Zeissig Y, Petersen B-S, Milutinovic S, Bosse E, Mayr G, Peuker K, et al. XIAP variants in male Crohn\u2019s disease. Gut. 2014;64:66\u201376.","journal-title":"Gut"},{"key":"1885_CR57","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1053\/j.gastro.2020.02.023","volume":"158","author":"E Crowley","year":"2020","unstructured":"Crowley E, Warner N, Pan J, Khalouei S, Elkadri A, Fiedler K, et al. Prevalence and clinical features of inflammatory bowel diseases associated with monogenic variants, identified by whole-exome sequencing in 1000 children at a single center. Gastroenterology. 2020;158:2208\u201320.","journal-title":"Gastroenterology"},{"key":"1885_CR58","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/nprot.2017.044","volume":"12","author":"S Wirtz","year":"2017","unstructured":"Wirtz S, Popp V, Kindermann M, Gerlach K, Weigmann B, Fichtner-Feigl S, et al. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat Protoc. 2017;12:1295\u2013309.","journal-title":"Nat Protoc"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01885-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01885-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01885-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:15:14Z","timestamp":1792041314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01885-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":58,"alternative-id":["1885"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01885-5","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Animal experiments were carried out in accordance with the guidelines and regulations of the Animal Management and Ethics Committee of Wenzhou Medical University and were formally approved (Approval No. wydw2023-0612, wydw2025-0565, and wydw2025-0564). The protocol for the study of clinical samples was reviewed and approved by the Ethics Committee in Clinical Research (ECCR) of the First Affiliated Hospital of Wenzhou Medical University (Approval No: KY2023-R182 and KY2025-R153). All procedures were carried out in full compliance with the ethical principles of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}